PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2015
Total Assets: $239.8M
Liabilities Breakdown FY2015
Total Liabilities: $33.8M
Asset Breakdown
Total Assets: $239.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $31.6M | 13.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.4M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $205.9M | 85.8% |
Liabilities Breakdown
Total Liabilities: $33.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $17.8M | 52.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.0M | 47.4% |